Remicade Safety Line (Ankylosing Spondylitis)

Trial Profile

Remicade Safety Line (Ankylosing Spondylitis)

Phase of Trial: Phase III

Latest Information Update: 06 Oct 2015

At a glance

  • Drugs Infliximab (Primary)
  • Indications Ankylosing spondylitis
  • Focus Adverse reactions
  • Sponsors Schering-Plough
  • Most Recent Events

    • 31 Jan 2012 Actual patient number changed from 323 to 320 as reported by
    • 28 Jan 2011 Status changed from active, no longer recruiting to completed as reported by
    • 20 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top